Celsius has launched with a $65 million series A financing. The start-up will combine single-cell genomics with machine learning algorithms to pinpoint specific cells that influence disease and identify the gene that triggers the fault. Traditional genomic sequencing cannot identify these individual contributions, as only the average can be seen and key critical causescan be missed. Celsius aims to use its method to develop precision medicine for autoimmune diseases and cancer. The financing was led by Third Rock Ventures , with participation from Third Rock Ventures , GV , Aviv , Alexandria Venture Investments and others.
Celsius has launched with a $65 million series A financing. The start-up will combine single-cell genomics with machine learning algorithms to pinpoint specific cells that influence disease and identify the gene that triggers the fault. Celsius aims to use its method to develop precision medicine for autoimmune diseases and cancer. The financing was led by Third Rock Ventures , with participation from Third Rock Ventures , GV , Aviv , Alexandria Venture Investments and others.